SecBot SecBot
6-K ·Filed Sep 1, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago SEC0001654954-26-008044
Actionable Insight • Neutral

No actionable trading signal. This is a routine voting rights notification with no impact on fundamentals, guidance, or capital structure. Monitor next earnings release or material event for directional cues.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$50.66
T+0 close · Sep 1, 2026 · via day close
Latest settled
−3.93%
T+20 · $48.67 · next T+60 in 8d
Vs SPY
−5.11%
α at T+20
Latest observation
+0.28%
T+50 · FF3 residual α
  1. T+0 · Sep 1 $50.66entry
  2. T+1 · 3mo ago −0.43%α −0.88% · $50.44
  3. T+5 · 2mo ago −4.01%α −4.09% · $48.63
  4. T+20 · 7w ago −3.93%α −5.11% · $48.67
  5. T+53 · todayOpen
  6. T+60 · in 8d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GSK filed a routine Total Voting Rights notification under UK Disclosure Guidance and Transparency Rule 5.6.1R, disclosing its issued share capital as of 31 August 2026. The filing confirms 4,316,302,379 ordinary shares outstanding, with 270,881,064 held in treasury, resulting in 4,045,421,315 voting rights. This is a standard administrative disclosure with no material financial or operational impact.

Key Facts

  • Issued share capital as of 31 August 2026: 4,316,302,379 ordinary shares of 31.25 pence each.
  • Treasury shares: 270,881,064.
  • Total voting rights: 4,045,421,315.
  • Filing is a routine monthly disclosure under FCA DTR 5.6.1R.

Financial Impact

No financial impact, routine administrative disclosure.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
44% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (GSK), Batch item 10001654954-26-008044
Document: 0001654954-26-008044-index-headers.html0001654954-26-008044
Document: 0001654954-26-008044-index.html0001654954-26-008044
Document: 0001654954-26-008044.txt0001654954-26-008044
6-K Filing (GSK), Batch item 50001654954-26-008044
Document: 0001654954-26-008044-index-headers.html0001654954-26-008044
Document: 0001654954-26-008044-index.html0001654954-26-008044
Document: 0001654954-26-008044.txt0001654954-26-008044

US Market Status

Market Closed · Opens Wed (10h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 1, 2026